Resources

Real World Evidence Groups
CanREValue Partner Websites
Canadian Agency for Drugs and Technologies in Health (CADTH)
Canadian Centre for Applied Research in Cancer Control (ARCC)
Canadian Partnership Against Cancer (CPAC)
Canadian Association of Provincial Cancer Agencies (CAPCA)
Institut national d’excellence en santé et services sociaux (INESSS)
Ontario Ministry of Health and Long-Term Care
Working Group Member Organizations
**Under Construction**
The following organizations are represented on one or more CanREValue Working Group:
Canadian Agency for Drugs and Technologies in Health (CADTH)
CADTH/pan-Canadian Oncology Drug Review (pCODR)
Canadian Centre for Applied Research in Cancer Control (ARCC)
Canadian Partnership Against Cancer (CPAC)
Canadian Association of Provincial Cancer Agencies (CAPCA)
Centre for Addiction and Mental Health (CAMH)
Harvard T.H. Chan School of Public Health
The Hospital for Sick Children
Institut national d’excellence en santé et services sociaux (INESSS)
London School of Hygiene & Tropical Medicine
Ontario Ministry of Health and Long-Term Care
pan-Canadian Pharmaceutical Alliance (pCPA)
Recent Projects
Patient perspectives of Value Frameworks used to Guide Oncology Treatment DecisionsMay 1, 2021 - 12:27 pm
Understanding British Columbia cancer patients’ experiences with virtual health before and during the COVID-19 pandemicMay 1, 2021 - 11:53 am
Benchmarking End of Life Quality Indicators by Tumor Type & Describing models of palliative care across CanadaApril 1, 2021 - 8:56 am
Evaluation of the systemic cancer therapy volume-outcome association: a population-based study to inform the optimal provincial organization and delivery of systemic cancer therapyFebruary 1, 2021 - 12:20 pm
RECENT POSTS
CADTH Call for Nominations – Board of DirectorsApril 20, 2023 - 7:50 am
#CCRC2023 – Abstract Submission is Now Open!April 13, 2023 - 8:26 am
2023 PIP Research Grant Competition for Postdoctoral FellowsApril 4, 2023 - 8:19 am
New Publication: Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) CollaborationMarch 28, 2023 - 1:56 pm